Sponsor Pipeline

Grupo de Estudos da Retina Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-12 NCT07761039 Real-World Study of Intravitreal Aflibercept 8 mg in Pretreated Eyes With nAMD or DME Not Yet Recruiting
Active Trials by Phase
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07761039 Real-World Study of Intravitreal Aflibercept 8 mg in Pretreated Eyes With nAMD or DME nAMD Not Yet Recruiting
Get alerts when Grupo de Estudos da Retina's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free